Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation

Research To Practice | Oncology Videos

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

18d ago 1:29:08

QUICKTIME•Episode home

Featuring perspectives from Ms Marianne J Davies, Dr Alexander I Spira, Ms Jillian Thompson and Dr Helena Yu, including the following topics:

Introduction (0:00)
The Importance of EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) (7:02)
The Role of Osimertinib in Managing Localized and Locally Advanced NSCLC with an EGFR Mutation (11:58)
Established First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (32:38)
Newly Approved and Promising Investigational Approaches to First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (37:45)
Common Toxicities Associated with Amivantamab (45:07)
The Current and Future Management of Progressive NSCLC with an EGFR Mutation (55:06)
Tolerability and Other Practical Considerations with HER3-DXd (1:01:06)
Treatment for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations (1:18:26)

NCPD information and select publications

1297 episodes

#Science #Medicine #Cancer #Neillove #Oncology #Researchtopractice #Fitness #Dr Neil Love #Video